Viewing Study NCT02166905


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-03-03 @ 2:20 PM
Study NCT ID: NCT02166905
Status: COMPLETED
Last Update Posted: 2023-02-24
First Post: 2014-04-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Carcinoma View
None Ovarian Carcinoma View
None Primary Peritoneal Carcinoma View
Keywords: